Sources of drug information and their influence on the prescribing behaviour of doctors in a teaching hospital in Ibadan, Nigeria

Pan African Medical Journal

Volumn 9, Issue , 2011, Pages

  Oshikoya, Kazeem Adeola ^a   Oreagba, Ibrahim ^b   Adeyemi, Olayinka ^b  

^a LAGOS STATE UNIVERSITY   (Nigeria)

^b UNIVERSITY OF LAGOS   (Nigeria)

Author keywords

Doctors; Drug; Influence; Information source; Nigeria; Pharmaceutical company; Prescription; Promotion

Indexed keywords

ADULT; ARTICLE; DEMOGRAPHY; DRUG INDUSTRY; DRUG INFORMATION; FEMALE; HOSPITAL PHYSICIAN; HUMAN; MALE; NIGERIA; PHYSICIAN ATTITUDE; PRESCRIPTION; PROSPECTIVE STUDY; QUESTIONNAIRE; SELF REPORT; TEACHING HOSPITAL;

EID: 84856329301     PISSN: 19378688     EISSN: None     Source Type: Journal    
DOI: 10.4314/pamj.v9i1.71188     Document Type: Article

References (36)

1. Mossialos E, Walley T, Mrazek M. Regulating pharmaceuticals in Europe: an overiew. In Mossialos E, Mrazek M, Walley T, (eds). Regulating Pharmaceutical in Europe: striving for efficiency, equity and quality
2. Denig P, Haajer-Ruskamp FM, Zijsling Hox DH. How physicians choose drugs. Soc Sci Med. 1988;27(12):1381-6. This article on PubMed
3. Bradley C. Factors which influence the decision whether or not to prescribe: the dilemma facing general practitioners. Br J Gen Pract. 1992; 42: 454-8. This article on PubMed
4. Schumock GT, Walton SM, Park HY, Nutescu EA, Blackburn JC, Finley JM, Lewis RK. Factors that influence prescribing decisions. Ann Pharmacother. 2004; 38: 557-62. This article on PubMed
5. De Bakker D, Coffie D, Heerdink E, Van Dijk L, Groenewegen P. Determinants of the range of drugs prescribed in general practice: a crosssectional analysis. BMC Health Serv Res. 2007; 7: 132. This article on PubMed
6. Watkins C, Harvey I, Carthy P, Moore L, Robinson E, Brawn R. Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey. Qual Saf Health Care. 2003; 12: 29-34. This article on PubMed
7. Posser H, Almond S, Walley T. Influences on GPs' decision to prescribe new drugs: the importance of who says what. Fam Pract. 2003; 20: 61-8. This article on PubMed
8. Vancelik S, Beyhun NE, Acemoglu H, Calikoglu O. Impact of pharmaceutical promotion on prescribing decisions of general practitioners in Eastern Turkey. BMC Public Health. 2007 Jun 25;7:122. This article on PubMed
9. Shankar PR, Subish P. Disease Mongering. Singapore Med J. 2007; 48: 275-80. This article on PubMed
10. Moynihan R, Heath I, Henry D. Selling sickness: the pharmaceutical industry and disease mongering. BMJ. 2002; 324: 886-91. This article on PubMed
11. Payer L. Disease mongers: how doctors, drug companies and insurers are making you feel seek. New York: Willey and Sons, 1992: 292
12. Odusanya OO, Oyediran MA. Rational drug use at the primary health care centres in Lagos, Nigeria. Nig Q J Hosp Med. 2000; 10: 4-7
13. Oshikoya KA, Chukwura HA, Ojo OI. Evaluation of outpatient paediatric drug prescriptions in a teaching hospital in Nigeria for rational prescribing. Paediatr Perinat Drug Ther. 2006; 7:183-8
14. Lexchin J. Deception by design: pharmaceutical promotion in the third world. Kaur SR, Ed. Penang: Consumers International, 1995
15. World Health Organization. Ethical criteria for medicinal drug promotion. Geneva, 1988; p. 5
16. Norris P, Herxheimer A, Lexchin J, Mansfield P. Geneva: World Health Organization; 2005. Drug promotion: What we know, what we have yet to learn. Available at: http://apps.who.int/medicinedocs/pdf/s8109e/s8109e.pdf. Accessed 18 December, 2010
17. Carthy P, Harvey I, Brawn R, Watkins C. A study of factors associated with costs and variation in prescribing among GPs. Fam Pract. 2000; 17: 36-41. This article on PubMed
18. Hogerzeil H. Promoting rational prescribing: an international perspective. Br J Clin Pharmacol. 1995 Jan;39(1):1-6. This article on PubMed
19. Theodorou M, Tsiantou V, Pavlakis A, Maniadakis N, Fragoulakis V, Pavi E, Kyriopoulos J. Factors influencing prescribing behaviour of physicians in Greece and Cyprus: results from a questionnaire based survey. BMC Health Serv Res. 2009; 9:150. This article on PubMed
20. Ziegler MG, Lew P, Singer BC. The accuracy of drug information from pharmaceutical sales. JAMA. 1995; 273: 1296-8. This article on PubMed
21. Ijoma U, Onwuekwe I, Onodugo O, Aguwa E, Ejim E, Onyedum C, Onah L, Okwudire E, Ugwuonah G. Effect of promotional Strategies of pharmaceutical companies on doctors' prescription pattern in South-east Nigeria. TAF Prev Med Bull. 2010; 9:1-6
22. Guldal D, Semin S. The influence of drug companies advertising programs on physicians. Int J Health Serv. 2000; 30: 585-95. This article on PubMed
23. Akande TM, Aderibigbe SA. Influence of drug promotion on prescribing habits of doctors in a teaching hospital. Afr J Med Med Sci. 2007; 36: 207-11. This article on PubMed
24. Arroll B, Goodyear-Smith F, Patrick D, Kerse N, Harrison J, Halliwell J, Pearson J, Lay-Yee R, von Randow M. Prescribing information resources: use and preference by general practitioners: An exploratory survey of general practitioners: The overview Report to the Ministry of Health, Wellington, New Zealand, Ministry of Health; 2005
25. McGettigan P, Golden J, Fryer J, Chan R, Feely J. Prescribers prefer people: the sources of information used by doctors for prescribing suggest that the medium is more important than the message. Br J Clin Pharmacol. 2001; 51: 184-9. This article on PubMed
26. Ahmad SR, Bhutto ZA. A survey of paediatric prescribing and dispensing in Karachi. J Pak Med Assoc. 1990 Jun;40(6):126-30. This article on PubMed
27. Mintzes B. Should Canada allow direct-to-consumer advertising of prescription drugs? NO. Can Fam Physician. 2009 Feb;55(2):131, 133, 135 passim. This article on PubMed
28. Silverman M, Lydecher M, Lee PR. Bad medicine: the prescription drug industry in the third world. Stanford: Stanford University Press 1992: 9.
29. Spurling GK, Mansfield PR, Montgomery BD, Lexchin J, Doust J, Othman N, Vitry AI. Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review. PLOS Med. 2010; 7: e1000352. This article on PubMed
30. Carrin G. Drug prescribing: A discussion of its variability and (ir) rationality. Health Policy. 1987; 7: 73-94. This article on PubMed
31. Dorsch JL. Information needs of rural health professionals: a review of the literature. Bull Med Libr Assoc. 2000 Oct;88(4):346-54. This article on PubMed
32. Connelly DP, Rich EC, Curley SP, and Kelly JT. Knowledge resource preferences of family physicians. J Fam Pract. 1990 Mar;30(3):353-9. This article on PubMed
33. Williamson JW, German PS, Weiss R, Skinner EA, and Bowes F. Health science information management and continuing education of physicians: a survey of US primary care practitioners and their opinion leaders. Ann Intern Med. 1989 Jan 15;110(2):151-60. This article on PubMed
34. Saito S, Mukohara K, Bito S. Japanese practicing physicians' relationship with pharmaceutical representatives: a national survey. PLoS One. 2010 Aug 13;5(8):e12193. This article on PubMed
35. Alvero RGY, Panganiban DL. Teaching critical appraisal of medicinal drug promotions in a medical school. Available at: http://dcc2.bumc.bu.edu/prdu/ICIUM_Posters/2a1_text.htm. Accessed 20 December 2010
36. Wofford J, Ohl CA. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes. BMC Med Educ. 2005; 5: 5. This article on PubMed